ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Counselling and predictive testing for familial adenomatous polyposis in a rural South Indian community

Bittles, A and Savithri, HS and Murthy, VHS and Baskaran, G and Rao, AN and Kool, D and Edkins, E (1999) Counselling and predictive testing for familial adenomatous polyposis in a rural South Indian community. In: Journal of Medical Genetics, 36 . S72-S72.

[img] PDF
Cost_comparison_of_predictive.pdf - Published Version
Restricted to Registered users only

Download (155Kb) | Request a copy
Official URL: http://gut.bmj.com/content/44/5/698.abstract

Abstract

Background—Mutations of the APC gene cause familial adenomatous polyposis (FAP), a hereditary colorectal cancer predisposition syndrome.Aims—To conduct a cost comparison analysis of predictive genetic testing versus conventional clinical screening for individuals at risk of inheriting FAP, using the perspective of a third party payer. Methods—All direct health care costs for both screening strategies were measured according to time and motion, and the expected costs evaluated using a decision analysis model.Results—The baseline analysis predicted that screening a prototype FAP family would cost $4975/£3109 by molecular testingand $8031/£5019 by clinical screening strategy, when family members were monitored with the same frequency of clinical surveillance (every two to three years). Sensitivity analyses revealed that the genetic testing approach is cost saving for key variables including the kindred size, the age of screening onset, and the cost of mutation identification in a proband. However, if the APC mutation carriers were monitored at an increased (annual) frequency, the cost of the genetic screening strategy increased to $7483/ £4677 and was especially sensitive to variability in age of onset of screening, family size, and cost of genetic testing of at risk relatives. Conclusions—In FAP kindreds, a predictive genetic testing strategy costs less than conventional clinical screening, provided that the frequency of surveillance is identical using either strategy. An additional significant benefit is the elimination of unnecessary colonic examinations for those family members found to be noncarriers.

Item Type: Editorials/Short Communications
Additional Information: Copyright of this article belongs to BMJ Publishing Group.
Department/Centre: Others
Date Deposited: 03 Aug 2011 10:37
Last Modified: 03 Aug 2011 10:37
URI: http://eprints.iisc.ernet.in/id/eprint/38586

Actions (login required)

View Item View Item